Plasma homovanillic acid and family history of psychotic disorders in bipolar I patients.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 19162188)

Published in Pharmacol Res on December 30, 2008

Authors

Mercedes Zumárraga1, Ricardo Dávila, Nieves Basterreche, Aurora Arrue, Biotza Goienetxea, Miguel Angel González-Torres, José Guimón

Author Affiliations

1: Departamento de Investigación Neuroquímica, Hospital Psiquiátrico de Zamudio, Arteaga Auzoa No 45, E-48170 Zamudio, Vizcaya, Spain. mercedes.zumarragaortiz@osakidetza.net

Articles by these authors

Downregulation of neuronal cdk5/p35 in opioid addicts and opiate-treated rats: relation to neurofilament phosphorylation. Neuropsychopharmacology (2003) 0.91

Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment. Neuropsychopharmacology (2004) 0.86

Regulation of GRK 2 and 6, beta-arrestin-2 and associated proteins in the prefrontal cortex of drug-free and antidepressant drug-treated subjects with major depression. Brain Res Mol Brain Res (2003) 0.85

GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients. Neurochem Res (2009) 0.85

The economic crisis in Spain and its impact on the mental health of children and adolescents. Eur Child Adolesc Psychiatry (2013) 0.80

Effects of age, postmortem delay and storage time on receptor-mediated activation of G-proteins in human brain. Neuropsychopharmacology (2002) 0.79

G protein-coupled receptor kinases, beta-arrestin-2 and associated regulatory proteins in the human brain: postmortem changes, effect of age and subcellular distribution. Brain Res Mol Brain Res (2002) 0.78

The influence of the Val158Met catechol-O-methyltransferase polymorphism on the personality traits of bipolar patients. PLoS One (2013) 0.78

Role of GIRK channels on the noradrenergic transmission in vivo: an electrophysiological and neurochemical study on GIRK2 mutant mice. Int J Neuropsychopharmacol (2012) 0.78

Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms. Psychiatry Res (2007) 0.76

Variability of plasma homovanillic acid over 13 months in patients with schizophrenia; relationship with the clinical response and the Wisconsin card sort test. Neurochem Res (2011) 0.76

Biological correlates of the congruence and incongruence of psychotic symptoms in patients with type 1 bipolar disorder. Neuropsychobiology (2008) 0.76

Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. Neurochem Int (2010) 0.76

Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder--a preliminary report. J Affect Disord (2006) 0.75

Plasma variations in stress markers: clinical trial of two anesthetics used in regional block in the extraction of impacted inferior third molars. Med Oral Patol Oral Cir Bucal (2014) 0.75

Inter- and intra-individual variability in the levels of plasma homovanillic acid in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.75

[Why don't we talk about negative psychotic symptoms in affective bipolar disorder?]. Rev Psiquiatr Salud Ment (2012) 0.75

Aripiprazole reverses paliperidone-induced hyperprolactinemia. Actas Esp Psiquiatr (2012) 0.75